{
  "docId": "019de072-95ca-731a-9896-42747d7adc13",
  "docSlug": "33535989d43f8c82917f7de34c9c9d29",
  "documentTitle": "AbCellera | Investor Conference Presentation Deck | 25 slides",
  "authorId": "abcellera",
  "authorName": "AbCellera",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-05-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 11,
  "pageCount": 25,
  "prevPage": 10,
  "nextPage": 12,
  "slideType": "comparison_table",
  "function": "compare_peers",
  "density": "balanced",
  "nDataPoints": 4,
  "notes": "The slide uses a contrast-pairs approach to highlight the strategic differentiation of AbCellera.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de072-95ca-731a-9896-42747d7adc13/11",
  "deckHref": "/decks/019de072-95ca-731a-9896-42747d7adc13",
  "deckJsonHref": "/decks/019de072-95ca-731a-9896-42747d7adc13.json",
  "deckAnchorHref": "/decks/019de072-95ca-731a-9896-42747d7adc13#slide-11",
  "components": [
    {
      "bbox": {
        "h": 0.3,
        "w": 0.28,
        "x": 0.07,
        "y": 0.38
      },
      "kind": "paragraph",
      "text": "We are building a large diversified portfolio that we believe will generate long-term value and superior returns without the volatility and risks normally associated with drug development.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9b1f91d1-73da-4dab-9962-e5ce9aaf414b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.63,
        "x": 0.34,
        "y": 0.35
      },
      "kind": "table",
      "text": "Comparison table of Traditional Biotech vs AbCellera across Time, Investment, Revenue, and Probability of Success.",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f7594315-28ba-454f-87b2-2d81ff057f66",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.45,
        "x": 0.07,
        "y": 0.1
      },
      "kind": "title",
      "text": "STRATEGY DICTATES THE BUSINESS MODEL",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7b712d78-4326-42f5-b5fa-f3cc104b566f",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Comparison frame",
      "slug": "comparison-frame",
      "agent": null,
      "layer": "slide",
      "matchId": "c4acb96f-fe51-4b0c-8f12-127ea1fbaab9",
      "evidence": "table/data: Comparison table of Traditional Biotech vs AbCellera across Time, Investment, Revenue, and Probability of Success.",
      "confidence": 0.7
    }
  ],
  "frameworks": [
    {
      "name": "comparison-frame",
      "slug": null,
      "matchId": "4bdc0ff1-3686-4fa7-aeef-48fd8e6c49c1",
      "evidence": "Direct comparison table between two business models.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 14,
      "from": 11,
      "beatId": "10c39d61-f9b1-4d88-9f74-bdc79d2f4de1",
      "arcName": "The Consultant's Gambit",
      "arcSlug": "consultants-gambit",
      "beatName": "Evidence & Proof",
      "beatSlug": "consultants-gambit-evidence-proof",
      "evidence": "Slides 11-14 provide evidence and validation of AbCellera's platform.",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}